Timing is everything in life: Conditional transgene expression in the cardiovascular system

Circulation Research

Volumn 82, Issue 8, 1998, Pages 837-844

  Fishman, Glenn I ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Chimeric transcription; Conditional; Gene expression; Mouse genome; Transgenic

Indexed keywords

GENE PRODUCT; TRANSCRIPTION FACTOR;

CARDIOVASCULAR SYSTEM; CHIMERA; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; GENETIC MANIPULATION; GENOME; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; TIME; TRANSGENE;

EID: 0032482138     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.8.837     Document Type: Short Survey

References (72)

1. Sauer F, Tjian R. Mechanisms of transcriptional activation: differences and similarities between yeast, Drosophila, and man. Curr Opin Genet Dev. 1997;7:176-181.
2. Fishman GI. Conditional transgenics. Trends Cardiovasc Med. 1995;5:211-217.
3. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992;89:5547-5551.
4. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 1991;266:24613-24620.
5. American Heart Association. Abstracts from the 70th Scientific Sessions. Circulation. 1997;96(suppl I):I-1-I-901.
6. Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM. Cardiacspecific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J Card Fail. 1997;3:117-124.
7. Hein L, Stevens ME, Barsh GS, Pratt RE, Kobilka BK, Dzau VJ. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A. 1997;94:6391-6396.
8. Charng M-J, Frenkel PA, Lin Q, Olson EN, Overbeek PA, Schneider MD. Constitutive signaling by ALK5 disrupts normal looping morphogenesis in transgenic mice [abstract]. Circulation. 1997;96(suppl I):I-512.
9. Nadal-Ginard B, Mahdavi V. Molecular mechanisms of cardiac gene expression. Basic Res Cardiol. 1993;88:65-79.
10. Nadal-Ginard B, Mahdavi V. Basic mechanisms of cardiac gene expression. Eur Heart J. 1993;14:2-11.
11. van Bilsen M, Chien KR. Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc Res. 1993;27:1140-1149.
12. Parker TG. Molecular biology of cardiac growth and hypertrophy. Herz. 1993;18:245-255.
13. Colbert MC, Hall DG, Kimball TR, Witt SA, Lorenz JN, Kirby ML, Hewett TE, Klevitsky R, Robbins J. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest. 1997;100:1958-1968.
14. Bowman JC, Steinberg SF, Jiang T, Geenen DL, Fishman GI, Buttrick PM. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest. 1997;100:2189-2195.
15. Soonpaa MH, Koh GY, Pajak L, Jing S, Wang H, Franklin MT, Kim KK, Field LJ. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest. 1997;99:2644-2654.
16. Natesan S, Rivera VM, Molinari E, Gilman M. Transcriptional squelching re-examined [letter]. Nature. 1997;390:349-350.
17. Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature. 1987;329:219-222.
18. MacKinnon R. Determination of the subunit stoichiometry of a voltage- activated potassium channel. Nature. 1991;350:232-235.
19. Redfern CH, Coward P, Degtyarev MY, Lee EK, Fishman GI, Conklin BR. Conditional expression of an engineered Gi-coupled receptor in transgenic mouse myocardium leads to bradycardia and signs of congestive heart failure [abstract]. Circulation. 1997;96(suppl I):I-181.
20. Ringold GM. Regulation of mouse mammary tumor virus gene expression by glucocorticoid hormones. Curr Top Microbiol Immunol. 1983;106:79-103.
21. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269:1427-1429.
22. Palmiter RD, Norstedt G, Gelinas RE, Hammer RE, Brinster RL. Metallothionein-human GH fusion genes stimulate growth of mice. Science. 1983;222:809-814.
23. Labow MA, Baim SB, Shenk T, Levine AJ. Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells. Mol Cell Biol. 1990;10:3343-3356.
24. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A. 1994;91:9302-9306.
25. Passman RS, Fishman GI. Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest. 1994;94:2421-2425.
26. Yu Z, Redfern CS, Fishman GI. Conditional transgene expression in the heart. Circ Res. 1996;79:691-697.
27. Baim SB, Labow MA, Levine AJ, Shenk T. A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl beta-D-thiogalactopyranoside. Proc Natl Acad Sci U S A. 1991;88:5072-5076.
28. Hillen W, Berens C. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu Rev Microbiol. 1994;48:345-369.
29. Wu R, Bahl CP, Narang SA. Lactose operator-repressor interaction. Curr Top Cell Regul. 1978;13:137-178.
30. Fischer A, Seiler SH, Huang Q, Horner JW, Morley GE, Vaidya DM, Jalife JW, Fishman GI. Conditional expression of diphtheria toxin A chain in the hearts of transgenic mice results in cardiac arrhythmias and sudden death [abstract]. Circulation. 1997;96(suppl I):I-182.
31. Husain M, Olson EN, Rosenberg RD. Conditional transgene expression in arterial smooth muscle [abstract]. Circulation. 1997;96(suppl I):I-501.
32. Li L, Miano JM, Cserjesi P, Olson EN. SM22α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res. 1996;78:188-195.
33. Efrat S, Fusco-DeMane D, Lemberg H, al Emran O, Wang X. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci U S A. 1995;92:3576-3580.
34. Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA, Hennighausen L. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science. 1996;273:1384-1386.
35. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER. Control of memory formation through regulated expression of a CaMKII transgene. Science. 1996;274:1678-1683.
36. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268:1766-1769.
37. van der Bijl P, Pitigoi-Aron G. Tetracyclines and calcified tissues. Ann Dent. 1995;54:69-72.
38. A-Mohammadi S. Delay in resumption of the activity of tetracyclineregulatable promoter following removal of tetracycline analogues. Gene Ther. 1997;4:993-997.
39. Baron U, Gossen M, Bujard H. Tetracyline controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 1997;25:2723-2729.
40. Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW. A regulatory system for use in gene transfer. Proc Natl Acad Sci U S A. 1994;91:8180-8184.
41. Wang Y, DeMayo FJ, Tsai SY, O'Malley BW. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol. 1997;15:239-243.
42. Christopherson KS, Mark MR, Bajaj V, Godowski PJ. Ecdysteroid- dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci U S A. 1992;89:6314-6318.
43. No D, Yao TP, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A. 1996;93:3346-3351.
44. Chien CT, Bartel PL, Sternglanz R, Fields S. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci U S A. 1991;88:9578-9582.
45. Ho SN, Biggar SR, Spencer DM, Schreiber SL, Crabtree GR. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature. 1996;382:822-826.
46. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F Jr, Holt DA, Gilman M. A humanized system for pharmacologic control of gene expression. Nat Med. 1996;2:1028-1032.
47. Liberles SD, Diver ST, Austin DJ, Schreiber SL. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc Natl Acad Sci U S A. 1997;94:7825-7830.
48. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989;10:374-378.
49. Kurihara Y, Kurihara H, Oda H, Maemura K, Nagai R, Ishikawa T, Yazaki Y. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest. 1995;96:293-300.
50. Kurihara H, Kurihara Y, Maemura K, Yazaki Y. The role of endothelin-1 in cardiovascular development. Ann N Y Acad Sci. 1997;811:168-176.
51. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant I. Cardiac malformation in neonatal mice lacking connexin43. Science. 1995;267:1831-1834.
52. Lo CW, Cohen MF, Huang GY, Lazatin BO, Patel N, Sullivan R, Pauken C, Park SM. Cx43 gap junction gene expression and gap junctional communication in mouse neural crest cells. Dev Genet. 1997;20:119-132.
53. Ewart JL, Cohen MF, Meyer RA, Huang GY, Wessels A, Gourdie RG, Chin AJ, Park SM, Lazatin BO, Villabon S, Lo CW. Heart and neural tube defects in transgenic mice overexpressing the Cx43 gap junction gene. Development. 1997;124:1281-1292.
54. Rossant J. Mouse mutants and cardiac development: new molecular insights into cardiogenesis. Circ Res. 1996;78:349-353.
55. Orban PC, Chui D, Marth JD. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A. 1992;89:6861-6865.
56. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 1994;265:103-106.
57. Sauer B. Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 1993;225:890-900.
58. Wang Y, Krushel LA, Edelman GM. Targeted DNA recombination in vivo using an adenovirus carrying the ere recombinase gene. Proc Natl Acad Sci U S A. 1996;93:3932-3936.
59. Brooks AI, Muhkerjee B, Panahian N, Cory-Slechta D, Federoff HJ. Nerve growth factor somatic mosaicism produced by herpes virus- directed expression of cre recombinase. Nat Biotechnol. 1997;15:57-62.
60. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD. Gene recombination in postmitotic cells: targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest. 1997;100:169-179.
61. Kellendonk C, Tronche F, Monaghan AP, Angrand PO, Stewart F, Schutz G. Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res. 1996;24:1404-411.
62. Metzger D, Clifford J, Chiba H, Chambon P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci U S A. 1995;92:6991-6995.
63. St-Onge L, Furth PA, Gruss P. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 1996;24:3875-3877.
64. Hanks M, Wurst W, Anson-Cartwright L, Auerbach AB, Joyner AL. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science. 1995;269:679-682.
65. Chen J, Chien KR. Cardiac restricted gene tareting of the RXRa gene reveals an essential, non-cell autonomous requirement of retinoid signals in ventricular chamber morphogenesis [abstract]. Circulation. 1997;96(suppl I):I-501.
66. Rose SD, MacDonald RJ. Integration of tetracycline regulation into a cell-specific transcriptional enhancer. J Biol Chem. 1997;272:4735-4739.
67. Gardin JM, Siri FM, Kitsis RN, Edwards JG, Leinwand LA. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res. 1995;76:907-914.
68. Siri FM, Jelicks LA, Leinwand LA, Gardin JM. Gated magnetic resonance imaging of normal and hypertrophied murine hearts. Am J Physiol. 1997;272:H2394-H2402.
69. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G. Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol. 1993;265:H1401-H1410.
70. Rockman HA, Ono S, Ross RS, Jones LR, Karimi M, Bhargava V, Ross J Jr, Chien KR. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A. 1994;91:2694-2698.
71. Christensen G, Wang Y, Chien KR. Physiological assessment of complex cardiac phenotypes in genetically engineered mice. Am J Physiol. 1997;272:H2513-H2524.
72. Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation. 1996;94:2641-2648.